The construction of a brand new large steroid building and a new warehouse on the Farmabios premises in Gropello Cairoli (Italy) is moving forward nearly in plan. After construction work began in Dec 2019 , we can now observe clear progress in construction in July 2020. Here you can see some impressions of the construction works. We will keep you up-dated on the progress regularly !
Farmabios expands its Manufacturing Footprint in Gropello Cairoli (Italy)
More News and Fairs
The construction of a brand new large steroid building and a new warehouse on the Farmabios premises in Gropello Cairoli (Italy) is moving forward nearly in plan. After construction work
Acquisition of PharmaZell Group by Bridgepoint completed. PharmaChol fully owned by the PharmaZell Group.
Bridgepoint, an international asset management firm with over €20 billion of assets, announced the acquisition of the PharmaZell Group in February 2020. After obtaining all necessary authorizations, we are very
Farmabios is pleased to announce that it has just finalized the production and distribution of sanitizing gels to Covid-19 task forces and structures which are serving the neighboring area, as
PharmaZell Group is very conscious of our important role and duty in delivering APIs to our customers and being an active part in maintaining the health system running. Up to
During this critical and challenging period, Farmabios SpA states that our activities are regularly proceeding. We are conscious of the role and duty in delivering APIs, and our active part
The PharmaZell Group management is very pleased to inform that the Group was acquired by Bridgepoint from DPE Deutsche Private Equity and Maxburg Capital Partners for an undisclosed sum. Bridgepoint
As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on
We are very glad to announce that the competent Italian authority (AIFA) has issued a renewed GMP certificate for our Farmabios SpA production facility [http://eudragmdp.ema.europa.eu/inspections/gmpc/generateGMPCPDF.do].
Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios